Cytokine adsorption and ECMO in patients with COVID-19
- PMID: 34242579
- PMCID: PMC8260102
- DOI: 10.1016/S2213-2600(21)00276-9
Cytokine adsorption and ECMO in patients with COVID-19
Conflict of interest statement
We declare no competing interests.
Comment in
-
Cytokine adsorption and ECMO in patients with COVID-19 - Author's reply.Lancet Respir Med. 2021 Aug;9(8):e72-e74. doi: 10.1016/S2213-2600(21)00274-5. Epub 2021 Jul 6. Lancet Respir Med. 2021. PMID: 34242580 Free PMC article. No abstract available.
Comment on
-
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial.Lancet Respir Med. 2021 Jul;9(7):755-762. doi: 10.1016/S2213-2600(21)00177-6. Epub 2021 May 14. Lancet Respir Med. 2021. PMID: 34000236 Free PMC article. Clinical Trial.
-
Cytokine adsorption and ECMO in patients with COVID-19.Lancet Respir Med. 2021 Aug;9(8):e71. doi: 10.1016/S2213-2600(21)00285-X. Epub 2021 Jul 6. Lancet Respir Med. 2021. PMID: 34242581 Free PMC article. No abstract available.
References
-
- Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. April 11, 2020. https://www.idsociety.org/practice-guideline/covid-19-guideline-treatmen... - PMC - PubMed
-
- Kogelmann K, Druener M, Jarczak D. Observations: early vs late use of CytoSorb haemoadsorption therapy in critically ill patients. Crit Care. 2016;20(suppl 2):195. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
